BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17429386)

  • 1. Genomics: global views of leukaemia.
    Golub TR
    Nature; 2007 Apr; 446(7137):739-40. PubMed ID: 17429386
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
    Mullighan CG; Goorha S; Radtke I; Miller CB; Coustan-Smith E; Dalton JD; Girtman K; Mathew S; Ma J; Pounds SB; Su X; Pui CH; Relling MV; Evans WE; Shurtleff SA; Downing JR
    Nature; 2007 Apr; 446(7137):758-64. PubMed ID: 17344859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered mRNA expression of PAX5 is a common event in acute lymphoblastic leukaemia.
    Santoro A; Bica MG; Dagnino L; Agueli C; Salemi D; Cannella S; Veltroni M; Cetica V; Giarin E; Fabbiano F; Basso G; Arico M
    Br J Haematol; 2009 Sep; 146(6):686-9. PubMed ID: 19604238
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
    Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
    Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare IgM multiple myeloma with aberrant PAX5 expression mimicking lymphoplasmacytic lymphoma.
    Xu Z; Van Der Jagt R; Faught C; Beaulieu Bergeron M
    Ann Hematol; 2014 Jul; 93(7):1251-2. PubMed ID: 24240978
    [No Abstract]   [Full Text] [Related]  

  • 6. Monocytoid switch in an adult with B-cell precursor acute lymphoblastic leukaemia characterised by the PAX5 P80R mutation.
    Mallik S; Yeung D; Rehn J; Nguyen T; Dunlop L; Kwan J; White D
    Pathology; 2022 Aug; 54(5):631-634. PubMed ID: 34924212
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of PML as novel PAX5 fusion partner in childhood acute lymphoblastic leukaemia.
    Nebral K; König M; Harder L; Siebert R; Haas OA; Strehl S
    Br J Haematol; 2007 Oct; 139(2):269-74. PubMed ID: 17897302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of PAX5 intragenic tandem multiplication in pediatric B-lymphoblastic leukemia by optical genome mapping.
    Jean J; Kovach AE; Doan A; Oberley M; Ji J; Schmidt RJ; Biegel JA; Bhojwani D; Raca G
    Blood Adv; 2022 Jun; 6(11):3343-3346. PubMed ID: 35245931
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mutation and expression of PAX5 gene in adult acute lymphoblastic leukemia].
    Lin ZK; Zhang R; Ge Z; Xu JY; Liu J; Guo X; Li M; Wu YJ; Qiao C; Qiu HR; Zhang JF; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1206-11. PubMed ID: 25338558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of PAX5 and C/EBP α/β in atypical non-Langerhans cell histiocytic tumor post acute lymphoblastic leukemia.
    Pagni F; Fazio G; Zannella S; Spinelli M; De Angelis C; Cusi C; Crosti F; Corral L; Bugarin C; Biondi A; Cazzaniga G; Isimbaldi G; Cattoretti G
    Leukemia; 2014 Jun; 28(6):1377-9. PubMed ID: 24569775
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomic analysis of clonal origin of Langerhans cell histiocytosis following acute lymphoblastic leukaemia.
    Kato M; Seki M; Yoshida K; Sato Y; Oyama R; Arakawa Y; Kishimoto H; Taki T; Akiyama M; Shiraishi Y; Chiba K; Tanaka H; Mitsuiki N; Kajiwara M; Mizutani S; Sanada M; Miyano S; Ogawa S; Koh K; Takita J
    Br J Haematol; 2016 Oct; 175(1):169-72. PubMed ID: 26537828
    [No Abstract]   [Full Text] [Related]  

  • 12. A PAX5 P80R pediatric B acute lymphoblastic leukemia with monocytic lineage switch at diagnosis: Deciphering classification ambiguity.
    Strullu M; Caye-Eude A; Fenneteau O; Arfeuille C; Cuccuini W; Cavé H; Baruchel A; Lainey E
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30842. PubMed ID: 38189777
    [No Abstract]   [Full Text] [Related]  

  • 13. B-cell identity--commitment is not forever.
    Nutt SL
    N Engl J Med; 2008 Jan; 358(1):82-3. PubMed ID: 18172181
    [No Abstract]   [Full Text] [Related]  

  • 14. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
    Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
    Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage.
    Schraders M; van Reijmersdal SV; Kamping EJ; van Krieken JH; van Kessel AG; Groenen PJ; Hoogerbrugge PM; Kuiper RP
    Cancer Genet Cytogenet; 2009 May; 191(1):27-33. PubMed ID: 19389505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside?
    Izraeli S
    Br J Haematol; 2010 Oct; 151(2):119-31. PubMed ID: 20678159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology and treatment of acute lymphoblastic leukemia.
    Pieters R; Carroll WL
    Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood B-cell precursor acute lymphoblastic leukaemia in a patient with familial thrombocytopenia and RUNX1 mutation.
    Linden T; Schnittger S; Groll AH; Juergens H; Rossig C
    Br J Haematol; 2010 Dec; 151(5):528-30. PubMed ID: 20880108
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of the Philadelphia chromosome in the iris of a child with acute lymphoblastic leukaemia.
    Buggage RR; Myers-Powell B; McManaway J; Shen D; Robinson MR; Chan CC
    Histopathology; 2005 Mar; 46(3):350-2. PubMed ID: 15720426
    [No Abstract]   [Full Text] [Related]  

  • 20. Genome study suggests new treatments for high-risk form of childhood leukemia.
    McBride D
    ONS Connect; 2012 Nov; 27(11):21. PubMed ID: 23316525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.